SCHEMBL2154041

SCHEMBL2154041

O=C(Cl)CCCCCCCCCC(=O)Cl

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 7/20 0.72
ALDH1A1 P00352 4/20 0.72
TP53 P04637 1/20 0.61
LMNA P02545 2/20 0.47
NFKB1 P19838 1/20 0.47
PMP22 Q01453 1/20 0.47
HDAC3 O15379 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
HDAC5 Q9UQL6 1/20 0.40
GPR84 Q9NQS5 5/20 0.38
CES2 O00748 3/20 0.38
CES1 P23141 3/20 0.38
FFAR1 O14842 2/20 0.38
FFAR4 Q5NUL3 2/20 0.38
PPARG P37231 6/20 0.36
PPARD Q03181 6/20 0.36
PPARA Q07869 6/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL495403 1.00 TSHR (0.72) TSHRALDH1A1TP53LMNANFKB1
SCHEMBL7329781 1.00 TSHR (0.72) TSHRALDH1A1TP53LMNANFKB1
SCHEMBL494763 1.00 TSHR (0.72) TSHRALDH1A1TP53LMNANFKB1
SCHEMBL6057206 1.00 TSHR (0.72) TSHRALDH1A1TP53LMNANFKB1
SCHEMBL494288 1.00 TSHR (0.72) TSHRALDH1A1TP53LMNANFKB1
SCHEMBL466419 1.00 TSHR (0.72) TSHRALDH1A1TP53LMNANFKB1
SCHEMBL495310 1.00 TSHR (0.72) TSHRALDH1A1TP53LMNANFKB1
SCHEMBL496221 1.00 TSHR (0.72) TSHRALDH1A1TP53LMNANFKB1
SCHEMBL2154814 1.00 TSHR (0.72) TSHRALDH1A1TP53LMNANFKB1
SCHEMBL2154590 1.00 TSHR (0.72) TSHRALDH1A1TP53LMNANFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240092780-A1 ADDUCTS AND DIMER COMPOUNDS SYNTHESIZED USING GK METHOD ANKH LIFE SCIENCES LIMITED (IE) 2024-03-21 US claimed
WO-2024050395-A1 ADDUCTS AND DIMER COMPOUNDS SYNTHESIZED USING GK METHOD ANKH LIFE SCIENCES LIMITED (IE) 2024-03-07 WO claimed
CN-110437445-B Polyamide resin and preparation method and application thereof 中仑塑业(福建)有限公司 2021-11-16 CN claimed
US-20260139106-A1 INSULATION FILM BASF SE (DE) 2026-05-21 US disclosed
EP-4688940-A1 HIGH-VOLTAGE RESISTANT POLYAMIDE COMPOSITION BASF SE (DE) 2026-02-11 EP disclosed
US-20260028470-A1 MOLDING COMPOSITION COMPRISING BLACK COLORANT BASF SE (DE) 2026-01-29 US disclosed
EP-4591331-A1 INSULATION FILM BASF SE (DE) 2025-07-30 EP disclosed
EP-4577599-A1 FLAME-RETARDANT POLYAMIDE COMPOSITION BASF SE (DE) 2025-07-02 EP disclosed
CN-119923696-A Insulating film 巴斯夫欧洲公司 2025-05-02 CN disclosed
CN-119768460-A Flame retardant polyamide composition 巴斯夫欧洲公司 2025-04-04 CN disclosed
US-20240336776-A1 POLYAMIDE COMPOSITIONS AND ARTICLE BASF SE (DE) 2024-10-10 US disclosed
US-4992464-A Bronchodilator, antiinflammatory, antiarthritic, antiallergenic agents ABBOTT LABORATORIES (US) 1991-02-12 US disclosed
EP-0077980-A2 (Potassium ion-selective membrane) electrode NOVA BIOMEDICAL CORPORATION (US) 1983-05-04 EP disclosed
US-4361473-A CROWN COMPOUNDS NOVA BIOMEDICAL CORPORATION (US) 1982-11-30 US disclosed
US-4212964-A FOR ADHESIVES PHILLIPS PETROLEUM COMPANY (US) 1980-07-15 US disclosed
US-4212965-A MOLDING MATERIAL, HOT MELT ADHESIVES, COATINGS PHILLIPS PETROLEUM COMPANY (US) 1980-07-15 US disclosed
US-4087481-A INJECTION MOLDING MATERIALS THE UPJOHN COMPANY (US) 1978-05-02 US disclosed
US-4072665-A Polyamide from arylene diamine, isophthalic acid and alkylene dicarboxylic acid THE UPJOHN COMPANY (US) 1978-02-07 US disclosed
US-4065441-A Copolyamide from arylene diamine and mixture of alkylene dicarboxylic acids THE UPJOHN COMPANY (US) 1977-12-27 US disclosed
US-4051087-A LAMINATES, ADHESIVES PHILLIPS PETROLEUM COMPANY (US) 1977-09-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260028470-A1 MOLDING COMPOSITION COMPRISING BLACK COLORANT MAP1LC3A, MAP1LC3C, MAP1LC3B TSHR 4684/4885ALDH1A1 3052/4885TP53 3258/4885
US-20260139106-A1 INSULATION FILM PAICS, KIF11, ABAT TSHR 4183/4885ALDH1A1 1535/4885TP53 4344/4885
US-20240092780-A1 ADDUCTS AND DIMER COMPOUNDS SYNTHESIZED USING GK METHOD DRD2, HNMT, DRD1 TSHR 2581/4885ALDH1A1 1683/4885TP53 2964/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.